SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-014156
Filing Date
2021-03-18
Accepted
2021-03-18 16:11:24
Documents
3
Period of Report
2021-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alxo-8k_20210318.htm 8-K 32296
2 EX-99.1 alxo-ex991_6.htm EX-99.1 278294
3 GRAPHIC gwcj0145p241000001.jpg GRAPHIC 8563
  Complete submission text file 0001564590-21-014156.txt   323646
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 21754453
SIC: 2834 Pharmaceutical Preparations